Evidence map›Paper›PMID 30968959›Full record

Trial reportPsychophysiology2019

Baseline resting heart rate variability predicts post-traumatic stress disorder treatment outcomes in adults with co-occurring substance use disorders and post-traumatic stress.

Heather E Soder, Margaret C Wardle, Joy M Schmitz, Scott D Lane, Charles Green, Anka A Vujanovic

Abstract readClinical Trial
In one paragraph

Trial report in Psychophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heather E SoderDepartment of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, Texas.
Margaret C WardleDepartment of Psychology, University of Illinois at Chicago, Chicago, Illinois.
Joy M SchmitzDepartment of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, Texas.
Scott D LaneDepartment of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, Texas.
Charles GreenDepartment of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, Texas.
Anka A VujanovicDepartment of Psychology, University of Houston, Houston, Texas.

Funding

Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
Translational MR Imaging in Cocaine Pharmacotherapy DevelopmentP50DA009262 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MOELLER, FREDERICK GERARD · 1994 to 2014
$26.9M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Center for Clinical and Translational Sciences (CCTS)KL2TR000370 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$4.3M
Targeting Anhedonia in Cocaine Use DisorderK08DA040006 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WARDLE, MARGARET · 2016 to 2020
$842k
NCATS NIH HHS KL2 TR000370NCATS NIH HHS UL1 TR000371NCATS NIH HHS UL1 TR003167NIDA NIH HHS K08 DA040006NIDA NIH HHS P50 DA009262NIH HHS 5K08DA040006-03NIH HHS KL2TR000370-07
6 · The paper itself

Abstract

Post-traumatic stress disorder (PTSD) symptoms are highly prevalent among individuals with substance use disorders (SUD), presenting a difficult-to-treat, complex comorbidity. Prognostic factors for treatment outcomes may characterize heterogeneity of the treated population and/or implicate mechanisms of action that are salient for improving treatments. High frequency heart rate variability (HF-HRV) is a suggested biomarker for emotion regulation-the ability to generate appropriate emotional responses via the influence of the parasympathetic nervous system on the heart. This initial study investigated the utility of baseline resting HF-HRV for predicting PTSD symptoms and substance use outcomes following treatment of 37 SUD participants with comorbid PTSD symptoms. Participants completed either standard cognitive- behavioral therapy (CBT) for SUD or a novel treatment of integrated post-traumatic stress and substance use that combined CBT for SUD with cognitive processing therapy for PTSD. Analyses demonstrated that higher HF-HRV predicted greater reduction in PTSD symptoms following both types of treatment. This suggests prognostic value of HF-HRV as a predictor of PTSD treatment outcomes; those with poorer autonomic emotional regulation may not respond as well to psychotherapy in general. This hypothesis-generating analysis identifies a putative biomarker that might have utility in treatment prediction.

Indexed as

Heart RateAdolescentAdultAgedAutonomic Nervous SystemBiomarkersEmotional RegulationFemaleHumansMaleMiddle AgedStress Disorders, Post-TraumaticSubstance-Related DisordersTreatment OutcomeYoung AdultBiomarkersheart rate variabilityPTSDsubstance usetraumatreatment

Identifiers

PMID30968959
PMCPMC6650323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.